Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today March 29
November 10, 2023 10:35
Aster Guardians Global Nursing Award 2024 Worth $250,000 to be Held in Bengaluru, India; Application Deadline Extended till 15th December
Aster Guardians Global Nursing Award 2024, an initiative by leading integrated healthcare provider Aster DM Healthcare, has extended the submission deadline to December 15th, 2023. Due to an overwhelm
November 09, 2023 10:15
Confluent Medical Sees Dramatic Improvements Around Supply Chain Visibility and Efficiency
Confluent Medical, a leading materials science, development and manufacturing partner to medical device manufacturers (“OEMs”), has experienced significant improvements to its end-to-end supply chain
November 09, 2023 09:50
Pharma Leader Dr. Holger Zimmermann Joins Lysando's Advisory Board in Pioneering Fight Against Antibiotic-Resistant Bacteria
Lysando, a leading innovator in the fight against antibiotic-resistant bacteria, proudly announces the appointment of Dr. Holger Zimmermann to its Advisory Board. Dr. Zimmermann‘s distinguished career
November 08, 2023 16:55
Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening
Crown Bioscience (https://www.crownbio.com/), a global contract research organization (CRO) and JSR Life Sciences company, today announced the launch of its ground-breaking service offering, OrganoidX
November 08, 2023 16:50
Mary Kay Ash Foundation℠ Celebrates Five Years Shaping the Future of Cancer Research in Partnership With UT Southwestern Medical Center
The Mary Kay Ash Foundation (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fmarykayashfoundation.org%2F&esheet=53709537&newsitemid=20231107256704&lan=en-US&anchor=The+Mary+Kay+Ash+F
November 08, 2023 10:48
Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Once-Daily TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis at American College of Rheumatology Convergence Annual Meeting
Takeda (TSE:4502/NYSE:TAK) today announced that the company will present positive results from its randomized, double-blind, placebo-controlled, Phase 2b trial evaluating TAK-279, an investigational o
November 07, 2023 14:05
HistoSonics Notches Significant Reimbursement Wins
HistoSonics, (www.histosonics.com), the manufacturer of the non-invasive Edison® Histotripsy System and novel sonic beam therapy, announced today that the Centers of Medicare & Medicaid Services (CMS)
November 05, 2023 10:20
Boehringer Ingelheim achieves major milestone in chronic kidney disease: aldosterone synthase inhibitor on top of empagliflozin delivers promising results in Phase II trial
Boehringer Ingelheim today announced promising 14-week Phase II data for BI 690517, a novel selective aldosterone synthase inhibitor (ASi). The results showed a significant reduction of albuminuria, a
November 05, 2023 09:50
Trailblazing the Future of Healthy Aging Science: Timeline® Hosts the First Global Urolithin A Summit With a Full-day Virtual Experience
On November 7th, the first global Urolithin A Scientific Summit, brought to the world stage by Timeline, is set to present paradigm-shifting research in the field of longevity. Led by experts in the s
November 03, 2023 09:10
GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies
GE HealthCare’s Artificial Intelligence (AI) models predict patient response to immunotherapies with 70 to 80 percent accuracy[1], based on a pan-cancer cohort, according to findings to be presented a
November 02, 2023 09:40
Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma
Resolian (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.resolian.com%2F&esheet=53720760&newsitemid=20231101490232&lan=en-US&anchor=Resolian&index=1&md5=1df79e5a4d8ec439af5c7de1
October 31, 2023 16:25
ReNAgade Therapeutics to Present Preclinical Data Demonstrating Potent Extra-Hepatic Delivery of mRNA Using Proprietary Lipid Nanoparticles at 11th International mRNA Health Conference
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced it will present preclinical data demonstrating novel and proprietary lipid nanoparticle (LNP)-base
October 30, 2023 17:37
Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate
Merck, a leading science and technology company, today announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Hengrui). The partnership includes an exclusive license worldw
October 29, 2023 12:30
United States International Trade Commission Issues Exclusion Order for Infringing Apple Watches, Finding that Apple Violated U.S. Trade Laws
Masimo (https://www.masimo.com/)(NASDAQ: MASI) today announced that the United States International Trade Commission (USITC) has recommended a limited exclusion order for infringing Apple Watches with
October 27, 2023 17:27
Boehringer Ingelheim’s SPEVIGO® (spesolimab) wins 2023 Prix Galien USA Best Orphan/Rare Diseases Solution Award
Boehringer Ingelheim today announced that SPEVIGO® (spesolimab) has been recognized as Best Orphan/Rare Diseases Solution of 2023 by the Galien Foundation. The Prix Galien USA Award was presented last
October 27, 2023 16:50
GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally
GC Aesthetics®, a long-established brand in breast aesthetics, and Bimini Health Tech (“Bimini”), a pioneer in healthcare solutions, are pleased to announce their groundbreaking Joint Venture partners
October 27, 2023 11:40
Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance
Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the first half of fiscal year 2023 (six months ended September 30, 2023), updating reported and Core forecasts and reconfirming Manag
October 26, 2023 14:25
Galderma Phase III Data Published in the New England Journal of Medicine: Full OLYMPIA 2 Trial Results Demonstrate Nemolizumab’s Rapid Onset of Action in Prurigo Nodularis Patients
Galderma today announced that the New England Journal of Medicine has published full results from the phase III OLYMPIA 2 trial evaluating the efficacy and safety of nemolizumab monotherapy in adults
October 26, 2023 14:10
EnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis
EnginZyme AB, a deep-tech company whose cell-free biomanufacturing technology uses the power of enzymes to create sustainable products and processes for a variety of industries, announced that it had
October 24, 2023 16:25
Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2
Iksuda Therapeutics (Iksuda), the developer of class leading antibody drug conjugates (ADCs) with enhanced tumour specificity, today announces that the first patient has completed a first cycle of the
October 24, 2023 09:00
ImmuneOncia Announces Positive Phase 1a Results of CD47 Monoclonal Antibody IMC-002 in Solid Tumors at ESMO 2023
ImmuneOncia (http://www.immuneoncia.com/immun/) (CEO Heung Tae Kim) announced the results of its Phase 1a solid tumour clinical trial (IMC-002-K102 Study) of IMC-002, a CD47 monoclonal antibody, at th
October 20, 2023 16:50
Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting.
Harshavardhan Sai Sadineni and Srived Meda of Kasturba Medical College, Manipal, India, won the XVIII Fujio Cup Quiz (FCQ) on Stem cells and Regenerative medicine (RM) in the NCRM NICHE 2023; Sri Rama
October 20, 2023 15:30
Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases
Aldena Therapeutics, a private biotech company pioneering siRNA- based therapies for dermatological indications, has chosen PCI Pharma Services (PCI) (https://pci.com/drug-development-manufacturing-se
October 20, 2023 10:20
New UVDI-GO™ UV LED Surface Sanitizer Inactivates High-Risk Microorganisms in 20 Seconds or Less
UltraViolet Devices, Inc. (UVDI), a leading manufacturer of advanced UV-C disinfection technology, announced today that the new UVDI-GO™ UV LED Surface Sanitizer is now available for use in healthcare
October 20, 2023 09:30
ViiV Healthcare to present 23 abstracts from innovative HIV treatment and prevention portfolio at EACS 2023
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the presentation of key abstracts highlighting the breadth of its ap
October 19, 2023 10:55
European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
Takeda (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.takeda.com&esheet=53633640&newsitemid=20231018884948&lan=en-US&anchor=Takeda&index=1&md5=4152f7bcff17087740131abae020a992)
October 18, 2023 15:30
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
Takeda (TSE:4502/NYSE: TAK) today announced that the Phase 3 ADMIRE-CD II study, assessing the efficacy and safety of Alofisel® (darvadstrocel) for the treatment of complex Crohn’s Perianal Fistulas (
October 18, 2023 14:54
Takeda Settles Tax Dispute with Irish Revenue over Break Fee Received by Shire
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=53624835&newsitemid=20231017233540&lan=en-US&anchor=TSE%3A4502%2FNYSE%
October 18, 2023 14:50
Neu REFIX β-glucan reduces muscle fibrosis in Duchenne muscular dystrophy MDX mice, in joint research with Dr. Yoshitsugu Aoki, NCNP, Tokyo, Japan.
Skeletal muscle fibrosis which leads to locomotor dysfunction in Duchenne Muscular Dystrophy (DMD) could be significantly reduced by oral consumption of Neu-REFIX beta 1,3-1,6 glucans alone for 45 day
October 18, 2023 10:10
Avania Bolsters MedTech CRO Value Chain Capabilities With Two Acquisitions in Highly Strategic Areas of Engineering Design & Product Development and Market Access
Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=53617459&newsitemid=20231017266904&lan=en-US&anchor=Avania&index=1&md5=37cd0200f76b717153750b
October 18, 2023 09:00
Sanofi Bridging the Gap between the Homeless and Society via Futsal
Sanofi in Korea, the Korean subsidiaries of the global healthcare company Sanofi, hosted the founding ceremony of the homeless futsal club ‘Dream’ together with Dalpengyee, a nonprofit organization, t
October 17, 2023 15:55
MMI Expands Global Footprint with Entry into Asia Pacific Market
MMI, (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that it will c
October 16, 2023 15:35
Merck to Present Latest Research from Oncology Portfolio at ESMO 2023
Merck, a leading science and technology company, today announced that 28 abstracts featuring the latest research on the company’s oncology portfolio addressing unmet needs across bladder, head and nec
October 15, 2023 12:01
Medisca Takes Additional Steps to Protect Its Innovative Technologies
Medisca has taken another step in protecting the strategic research and development (R&D) investments made decades ago that ultimately led to the industry-leading Medisca MAZ® mixer. The Medisca MAZ m
October 15, 2023 11:32
Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union Following Re-Examination Process
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) confirmed
October 15, 2023 11:11
Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event
Galderma, the emerging pure-play dermatology category leader, today hosts the first edition of its Liquid Live event in Dubai as a chance to discuss with clinicians the future of innovation in the fie
October 13, 2023 15:15
AstraZeneca Awards Funding to Eight Innovative Research Projects From Early-Career Scientists Around the World in Second R&D Postdoctoral Challenge
AstraZeneca announced today eight winners of the 2023 R&D Postdoctoral Challenge (https://openinnovation.astrazeneca.com/rd-postdoctoral-challenge.html) and agreed to fund their postdoctoral positions
October 13, 2023 14:40
AI Medical Service Inc. Signs Joint Research Agreement with Leading Vietnamese Medical Institution
AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research agreement with Institute of Gastroenterology and
October 12, 2023 13:31
SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based company, to develop, manufacture and commercialize SOFIE’s Gallium-68 and F
October 12, 2023 11:24
Galderma @ EADV 2023: Phase III Trials Demonstrate Nemolizumab’s Efficacy and Rapid Onset of Action in Atopic Dermatitis and Prurigo Nodularis
Galderma announced positive data from three pivotal phase III trials in atopic dermatitis and prurigo nodularis - ARCADIA 1 and 2 and OLYMPIA 1, respectively. The late-breaking data were presented tod
October 12, 2023 10:08
FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial
Care Access announced today the completion of a for-cause Food and Drug Administration (“FDA”) Good Clinical Practices (“GCP”) inspection related to Care Access’s activities on the Pfizer VALOR trial.
October 11, 2023 15:38
Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People with RMS
Not intended for UK and U.S. based media Merck, a leading science and technology company, today announced new five-year data from the open-label extension (OLE) of the Phase II clinical trial, whic
October 11, 2023 08:58
Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.
Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston® and
October 10, 2023 15:59
Merck Presents New MAVENCLAD® (Cladribine Tablets) Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation
Not intended for UK and U.S. based media Merck, a leading science and technology company, today announced the presentation of new analyses from the MAVENCLAD® (cladribine tablets) MAGNIFY-MS study,
October 10, 2023 13:45
Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring
Masimo (https://www.masimo.com/) (NASDAQ: MASI) today announced the CE mark, under the European Union Medical Device Regulation, for the LiDCO® board-in-cable (BIC) module. The LiDCO BIC module is des
October 10, 2023 11:10
FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System
HistoSonics®, (www.histosonics.com), the manufacturer of the Edison® System and novel histotripsy therapy platforms, announced today the marketing authorization of its “Breakthrough” platform via the
October 09, 2023 15:05
Phase III Studies to Investigate Survodutide for People Living with Obesity and Overweight, with and without Diabetes, Cardiovascular Disease and Chronic Kidney Disease
Boehringer Ingelheim and Zealand Pharma A/S (NASDAQ: ZEAL) announced the initiation of three Phase III trials investigating survodutide (also known as BI 456906) for people living with overweight or o
October 06, 2023 14:30
Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years
Takeda (https://www.takeda.com/) (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE)
October 06, 2023 11:04
Merck Launches New Collaboration with United Nations-Guided Global Initiative on Ageing to Support Carers
Merck, a leading science and technology company, today announced a new collaboration with the United Nations-Guided Global Initiative on Ageing (GIA) to provide a training course on critical skills fo
October 05, 2023 11:38
Woman Reunited With the Nurse Who Helped Save Her Life 30 Years Ago
A woman was reunited this week with a nurse who saved her life 30 years ago as she volunteers for the same charity that her rescuers were from. In 1993, Catherine Conteh was enduring an agonizing f
October 04, 2023 15:05
EADV 2023: Galderma to Present New Data Showcasing Its Continued Leadership in Dermatology
Galderma, the emerging pure-play dermatology category leader, announced today it will be showcasing updates from across its broad and innovative dermatology portfolio at the 32nd European Academy of D
October 04, 2023 13:35
RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer
RoslinCT, a leading contract development and manufacturing organization (CDMO) for Advanced Cell and Gene Therapies, is pleased to announce the appointment of Dean J. Morris as the Chief Operations Of
October 04, 2023 11:10
Takeda Provides Update on EXKIVITY® (mobocertinib)
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA to
October 03, 2023 11:57
Galderma announces progress with RelabotulinumtoxinA regulatory submissions
Galderma, the emerging pure-play dermatology category leader, announced today updates related to the regulatory progress of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA (Q
October 03, 2023 11:27
Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss
Boehringer Ingelheim and ZEISS Medical Technology announce today a long-term strategic collaboration to develop predictive analytics to enable early detection of eye diseases and prevent vision loss f
October 01, 2023 10:45
Organon Recognized on Fortune’s 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice
Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, has been named to Fortune’s 2023 Change the World list for its leadership in helping women and girls around the world t
September 27, 2023 10:40
Medisca Takes Steps to Protect its Innovative Technologies
Through decades of strategic research and development (“R&D”) investment, the Medisca name has become synonymous with innovative, customer-focused technologies. In compounding, for example, Medisca co
September 26, 2023 10:25
Korean Unicorn APR Files for Preliminary IPO Review on KRX
APR (https://www.apr-in.com/), a beauty-tech company APR (CEO Byung-hoon Kim) announced today that it filed for a preliminary review on the Korea Exchange (KRX) on September 22. Shinhan Securities
September 26, 2023 10:15
Aster Guardians Global Nursing Award 2024 is Now Open for Entry Worldwide, One Nurse Will Win the US $250,000 Award
In its continued efforts to recognize the contribution of nurses to humanity and the healthcare community, Aster DM Healthcare has announced the third edition of the Aster Guardians Global Nursing Awa
September 24, 2023 11:15
Kenvue to Announce Third Quarter 2023 Results on October 26, 2023
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will announce its financial results for the third quarter ending October 1, 2023, before market o
September 22, 2023 10:25
ReNAgade Therapeutics Named to the 2023 Endpoints 11
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced that it has been named as one of the Endpoints 11 companies of 2023 (https://endpts.com/the-endpoi
September 21, 2023 10:00
41st Geumsan World K-Insam Festival to Kick Off with a Variety of Festivities on October 6
The 41st Geumsan World K-Insam Festival (https://www.kdischool.ac.kr/board.es?mid=a10603000000&bid=0011&list_no=16746&act=view) will take place in Geumsan from October 6 to 15, 2023, to promote the ef
September 20, 2023 16:48
MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis
MRM Health NV, a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics, today reports positive topline results from its Phase 2a clinica
September 20, 2023 15:05
Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera Published in Medical Journal Leukemia
AOP Orphan Pharmaceuticals GmbH (AOP Health) announced the publication of final results on the recently developed interferon therapy, ropeginterferon alfa-2b, in patients with polycythemia vera (PV) i
September 20, 2023 14:29
Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
Merck, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery c
September 20, 2023 13:20
Julie Gerardi Joins Parse Biosciences as Vice President of Business Development
Parse Biosciences, (https://www.parsebiosciences.com/) a leading provider of accessible and scalable single cell sequencing solutions, today announced that Julie Gerardi has joined the company as vice
September 20, 2023 09:55
Takeda Commits Over $30 Million in Five New Global CSR Partnerships To Further Drive Health Impact in 92 Countries
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced five new partnerships to its Global Corporate Social Responsibility (CSR) Program, which contribute to strengthe
September 19, 2023 10:10
Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi
PRESS RELEASE - FOR TRADE, BUSINESS AND MEDICAL MEDIA ONLY Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of est
September 17, 2023 15:40
Biocytogen Officially Launches RenMice® Series
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) officially announces the RenMice® series, which includes a collection of independently developed, fully human antibody mice a
September 15, 2023 13:20
SK Capital Completes Strategic Investment in Ecopol
Ecopol S.p.A. (“Ecopol” or the “Company”), a leading developer and producer of innovative biodegradable films and delivery systems, announced today the completion of a strategic investment from affili
September 14, 2023 17:18
Boehringer Ingelheim receives SBTi validation for CO2 reduction targets
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, said on Thursday it is well on track to achieve its 2030 emission reduction targets, and that it had received approval of tho
September 14, 2023 16:55
Ahead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity
Ahead of discussions at the United Nations General Assembly (UNGA78), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has warned that current pandemic preparednes
September 14, 2023 16:19
AstraZeneca advances UK clean heat and energy efficiencies with £100m commitment
Powering AstraZeneca’s transition to net zero, the Company has agreed a 15-year partnership with Future Biogas to establish the UK’s first unsubsidised industrial-scale supply of biomethane gas, and i
September 14, 2023 09:45
ReNAgade Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Laurie Stelzer as Chief Financial Officer. Ms. Stelzer most recently served as
September 13, 2023 11:20
KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb (https://www.kbibiopharma.com/suremab-efficient-antibody-development)™, an offering built on the robustnes
«
1
2
3
4
5
»
75 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 162 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice